Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

All-Trans-Retinoic Acid Induction Overcomes Immune Evasion through Downregulating Immune Checkpoint Molecules and Inducing a Cytokine Storm Triggered By Overexpression of S100A8/A9 Signaling

Blood (2023) 142 (Supplement 1): 4335.

https://doi.org/10.1182/blood-2023-184432

Published: 2023

Journal Articles

11q Gain with t(11;14) or Alone Were Associated with Poor Prognosis in Newly-Diagnosed Multiple Myeloma Patients By SNP-Array Analysis and FISH

Blood (2023) 142 (Supplement 1): 1968.

https://doi.org/10.1182/blood-2023-184870

Published: 2023

Journal Articles

CNVs Numbers Scoring System Was a Good Prognostic Risk Stratification for NDMM with Whole Genomic Mapping Array

Zhao Zeng, Chengcheng Fu, Jinlan Pan, Jiao Lu, Jingjing Shang, Zhiyu Zhang, Hongying You, Wanhui Yan, Chunxiao Wu, Qinrong Wang, Qian Wang, Lijun Wen, Song Jin, Lingzhi Yan, Suning Chen, De-pei Wu

Blood (2023) 142 (Supplement 1): 4725.

https://doi.org/10.1182/blood-2023-184504

Published: 2023

Journal Articles

Venetoclax with decitabine as frontline treatment in younger adults with newly diagnosed ELN adverse-risk AML

Blood (2023) 142 (15): 1323–1327.

https://doi.org/10.1182/blood.2023020102

Published: 2023

Includes: Supplemental data

Journal Articles

TP53 Gene Deletion or Mutation in Newly Diagnosed Multiple Myeloma Patients By FISH with Cytoscan Arrays and Targeted Panel Sequencing

Hongying You, Hongjie Shen, Song Jin, Qingqing Wang, Shuang Yan, Yingying Zhai, Weiqin Yao, Xiaolan Shi, Jingjing Shang, Lingzhi Yan, Ying Yao, Jing Wang, Panfeng Wang, Jinlan Pan, Depei Wu, Chengcheng Fu

Blood (2022) 140 (Supplement 1): 4325–4327.

https://doi.org/10.1182/blood-2022-159272

Published: 2022

Journal Articles

The Independent Adverse Prognostic Significance of 1q21 Gain/Amplification in Newly Diagnosed Multiple Myeloma Patients

Hongying You, Song Jin, Chunxiao Wu, Qingqing Wang, Shuang Yan, Yingying Zhai, Weiqin Yao, Xiaolan Shi, Jingjing Shang, Lingzhi Yan, Ying Yao, Jing Wang, Panfeng Wang, Jinlan Pan, Depei Wu, Chengcheng Fu

Blood (2022) 140 (Supplement 1): 10056–10057.

https://doi.org/10.1182/blood-2022-159067

Published: 2022

Journal Articles

Targeting 1q21 Amplification with APG2575 and Lenalidomide to Sensitize BCL-2 Inhibition with the Decrease of MCL-1 Protein in High Risk MM Models

Yan Xie, MD, Chengcheng FU, MD PhD, Lingzhi Yan, MD PhD, Song Jin, MD, Jingjing Shang, MD, Xiaolan Shi, MD PhD, Jinlan Pan, MD, Yan Yin, MS, Tingting Mao, MS, Jing Deng, PhD, Douglas D. Fang, MD PhD, Dajun Yang, MD PhD, Yifan Zhai, MD PhD, Shuang Yan, MD, Yingying Zhai, MD, Ying Yao, MD, Panfeng Wang, MD, Jing Wang, MD, Depei Wu, MDPhD

Blood (2020) 136 (Supplement 1): 46–47.

https://doi.org/10.1182/blood-2020-139195

Published: 2020

Journal Articles

Effectiveness of First and Second Line Nilotinib in Chronic Myeloid Leukemia (CML) Patients with Atypical e1a2 BCR-ABL Transcripts

Xiaomin Gui, Jinlan Pan, Huiying Qiu, Jiannong Cen, Yongquan Xue, Suning Chen, MD PhD, Jun He, Hongjie Shen, Li Yao, Jun Zhang, Yafang Wu, Wu Depei, MD

Blood (2014) 124 (21): 5520.

https://doi.org/10.1182/blood.V124.21.5520.5520

Published: 2014

Journal Articles

A Novel Recurrent Chromosomal Inversion, Inversion(9)(p21q34), in Ph-Positive Leukemia Patients.

Jinlan Pan, Jun Zhang, Yongquan Xue, Yafang Wu, Juan Shen, Yong Wang, Dandan Liu, Suning Chen

Blood (2009) 114 (22): 4242.

https://doi.org/10.1182/blood.V114.22.4242.4242

Published: 2009

Journal Articles

Chromosome Study On Chronic Lymphocytic Leukemia Using CpG- Oligodeoxynucleotide as Immunostimulant Agent.

Yafang Wu, Yongquan Xue, Li Yao, Hui Jiang, Jun Zhang, Juan Shen, Jinlan Pan, Yong Wang, Shuxiao Bai, Suning Chen

Blood (2009) 114 (22): 4383.

https://doi.org/10.1182/blood.V114.22.4383.4383

Published: 2009

Journal Articles

Study On the Clonal Origin of Dysplastic Cells by Fluorescence in Situ Hybridization in Myelodysplastic Syndromes.

Jun Zhang, Yongquan Xue, Jinlan Pan, Yafang Wu, Juan Shen, Yong Wang, Dandan Liu, Suning Chen

Blood (2009) 114 (22): 4858.

https://doi.org/10.1182/blood.V114.22.4858.4858

Published: 2009

Journal Articles

Pulmonary Alveolar Proteinosis as a Terminal Complication in a Case of Myelodysplastic Syndrome with Idic(20q-).

Yongquan Xue, Yongsheng Han, Tianyu Li, Suning Chen, Jun Zhang, Jinlan Pan, Yafang Wu, Yong Wang, Juan Shen

Blood (2009) 114 (22): 4864.

https://doi.org/10.1182/blood.V114.22.4864.4864

Published: 2009

Journal Articles

Der(20)idic(20)(p11)del(20)(q11q13) Is Seen Not Only in Myeloid Disorders but Also in Lymphoid Disorders: A Report of Further Seven Cases.

Tianyu Li, PhD, Yongquan Xue, PhD, Jun Zhang, MM, Suning Chen, PhD, Jinlan Pan, MM, Yafang Wu, MM

Blood (2007) 110 (11): 4126.

https://doi.org/10.1182/blood.V110.11.4126.4126

Published: 2007

Journal Articles

Two Novel Translocations That Disrupt the RUNX1 Gene in Acute Myeloid Leukemia.

Haiping Dai, PhD, Yongquan Xue, PhD, Jinlan Pan, MM, Yafang Wu, MM, Yong Wang, MM, Juan Shen, Jun Zhang, MM

Blood (2007) 110 (11): 4127.

https://doi.org/10.1182/blood.V110.11.4127.4127

Published: 2007

Journal Articles

The Establishment and Characterization of a Human Acute Myelocytic Leukemia Cell Line, SH-2 Carrying t(16;17))(q24;q12) Translocation.

Huiying Qiu, PhD, Yongquan Xue, PhD, Jinlan Pan, MM, Yafang Wu, MM, Yong Wang, MM

Blood (2007) 110 (11): 4128.

https://doi.org/10.1182/blood.V110.11.4128.4128

Published: 2007

Journal Articles

Trisomy 22 as the Sole Abnormality Is an Important Marker for Inversion 16 in Acute Myeloid Leukemia.

Jianyong Li, Huifen Zhou, Lijuan Chen, Jinlan Pan, Hairong Qiu, Wei Xu, Yongquan Xue, Hua Lu

Blood (2006) 108 (11): 4445.

https://doi.org/10.1182/blood.V108.11.4445.4445

Published: 2006

Journal Articles

Fluorescence In Situ Hybridization Studies in 22 Cases of Plasma Cell Leukemia.

Jianyong Li, MD, PhD, Wei Xu, M.D. Ph D., Lijuan Chen, M.D. Ph D., Yu Zhu, M.D., Jinlan Pan, M.D., Hairong Qiu, M.D., Yongquan Xue, M.D. Ph D., Hua Lu, M.D.

Blood (2006) 108 (11): 4461.

https://doi.org/10.1182/blood.V108.11.4461.4461

Published: 2006

Journal Articles

Interphase Fluorescence In Situ Hybridization Detection of Cytogenetic Abnormalities in B-Cell Chronic Lymphocytic Leukemia.

Wei Xu, MD, Jianyong Li, MD, PhD, Jinlan Pan, MD, Li Li, MD, Hairong Qiu, PhD, Yongquan Xue, MD, Changgeng Ruan, MD, PhD

Blood (2005) 106 (11): 4992.

https://doi.org/10.1182/blood.V106.11.4992.4992

Published: 2005

Journal Articles

Multiplex Fluorescence In Situ Hybridization (M-FISH) in the Detection of Complex Karyotypic Abnormalities of Acute Myeloid Leukemia and Myelodysplastic Syndromes.

Jianyong Li, MD, PhD, Jinlan Pan, PhD, Bing Xiao, MD, Li Ma, MD, Hairong Qiu, PhD, Li Li, MD, Wei Xu, MD, Yongquan Xue, MD, Changgeng Ruan, MD.PhD

Blood (2005) 106 (11): 4504.

https://doi.org/10.1182/blood.V106.11.4504.4504

Published: 2005

Journal Articles

Preliminary Study of Inducing Differentiation and Apoptosis in a Novel Human Acute Monocytic Leukemic Cell Line SHI-1.

Suning Chen, MD, PhD, Yongquan Xue, MDPhD, Yafang Wu, PhD, Jinlan Pan, Ph.D, De Pei Wu, MD, PhD

Blood (2005) 106 (11): 4297.

https://doi.org/10.1182/blood.V106.11.4297.4297

Published: 2005

NARROW

All-Trans-Retinoic Acid Induction Overcomes Immune Evasion through Downregulating Immune Checkpoint Molecules and Inducing a Cytokine Storm Triggered By Overexpression of S100A8/A9 Signaling

11q Gain with t(11;14) or Alone Were Associated with Poor Prognosis in Newly-Diagnosed Multiple Myeloma Patients By SNP-Array Analysis and FISH

CNVs Numbers Scoring System Was a Good Prognostic Risk Stratification for NDMM with Whole Genomic Mapping Array

Venetoclax with decitabine as frontline treatment in younger adults with newly diagnosed ELN adverse-risk AML

TP53 Gene Deletion or Mutation in Newly Diagnosed Multiple Myeloma Patients By FISH with Cytoscan Arrays and Targeted Panel Sequencing

The Independent Adverse Prognostic Significance of 1q21 Gain/Amplification in Newly Diagnosed Multiple Myeloma Patients

Targeting 1q21 Amplification with APG2575 and Lenalidomide to Sensitize BCL-2 Inhibition with the Decrease of MCL-1 Protein in High Risk MM Models

Effectiveness of First and Second Line Nilotinib in Chronic Myeloid Leukemia (CML) Patients with Atypical e1a2 BCR-ABL Transcripts

A Novel Recurrent Chromosomal Inversion, Inversion(9)(p21q34), in Ph-Positive Leukemia Patients.

Chromosome Study On Chronic Lymphocytic Leukemia Using CpG- Oligodeoxynucleotide as Immunostimulant Agent.

Study On the Clonal Origin of Dysplastic Cells by Fluorescence in Situ Hybridization in Myelodysplastic Syndromes.

Pulmonary Alveolar Proteinosis as a Terminal Complication in a Case of Myelodysplastic Syndrome with Idic(20q-).

Der(20)idic(20)(p11)del(20)(q11q13) Is Seen Not Only in Myeloid Disorders but Also in Lymphoid Disorders: A Report of Further Seven Cases.

Two Novel Translocations That Disrupt the RUNX1 Gene in Acute Myeloid Leukemia.

The Establishment and Characterization of a Human Acute Myelocytic Leukemia Cell Line, SH-2 Carrying t(16;17))(q24;q12) Translocation.

Trisomy 22 as the Sole Abnormality Is an Important Marker for Inversion 16 in Acute Myeloid Leukemia.

Fluorescence In Situ Hybridization Studies in 22 Cases of Plasma Cell Leukemia.

Interphase Fluorescence In Situ Hybridization Detection of Cytogenetic Abnormalities in B-Cell Chronic Lymphocytic Leukemia.

Multiplex Fluorescence In Situ Hybridization (M-FISH) in the Detection of Complex Karyotypic Abnormalities of Acute Myeloid Leukemia and Myelodysplastic Syndromes.

Preliminary Study of Inducing Differentiation and Apoptosis in a Novel Human Acute Monocytic Leukemic Cell Line SHI-1.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only